Production of high-titer Epstein-Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system
about
Production of viral vectors using recombinase-mediated cassette exchangeEarly events associated with infection of Epstein-Barr virus infection of primary B-cellsCloning human herpes virus 6A genome into bacterial artificial chromosomes and study of DNA replication intermediatesIdentification and characterization of CCAAT enhancer-binding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1.Unexpected instability of family of repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC systems.Herpesvirus BACs: past, present, and future.Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency.Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.Construction of an infectious rhesus rhadinovirus bacterial artificial chromosome for the analysis of Kaposi's sarcoma-associated herpesvirus-related disease developmentDifferentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial CellsThe Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells.The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuliThe Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells.Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell FactorHighly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.The biological properties of different Epstein-Barr virus strains explain their association with various types of cancersEpstein-Barr virus genetics: talking about the BAC generation.Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells.HLA-restricted presentation of WT1 tumor antigen in B-lymphoblastoid cell lines established using a maxi-EBV system.Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene.Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines.Epstein-Barr Virus (EBV): infection, propagation, quantitation, and storage.Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.Generation and Infection of Organotypic Cultures with Epstein-Barr Virus.Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro.Mutagenesis and Genome Engineering of Epstein-Barr Virus in Cultured Human Cells by CRISPR/Cas9.Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressorEpstein-Barr virus transforming protein LMP1 plays a critical role in virus production.Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells.Distinctive effects of the Epstein-Barr virus family of repeats on viral latent gene promoter activity and B-lymphocyte transformation.Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.Cloning of the herpes simplex virus type 1 genome as a novel luciferase-tagged infectious bacterial artificial chromosome.
P2860
Q24798297-2388A848-1F8B-49EB-8A44-7F1AF6924508Q28476230-C9DF93AA-2535-4777-95A4-4199F486830CQ29030728-9EFF66E8-CEB1-4D95-BC29-9F979C726C1FQ34052180-FAE6236A-4E2A-45F4-9720-C859B1CE2378Q34082799-B15CA736-CE24-4E04-A54C-F3A746131275Q34247863-5ACDC18F-63C0-43C5-9D0D-2392F5220A64Q34703035-686519D2-F2F5-43AB-ABE8-BE697094DDCAQ35363296-495AC212-4535-4C7C-93C3-494C3EAD66C0Q35540042-471C43E6-3500-4626-9E2B-33FF5219411DQ35784917-C94209FB-699B-4468-B538-F65B3396682DQ35797164-5625FD3F-4D86-4A40-BCA0-A3CA50E707A2Q35875632-BECF46EA-8BA6-4EB0-894C-8D4DF096D6DFQ36414572-0CA7A96A-A92E-4C1B-A7BF-482CD2FDD081Q36499480-CB3A79E7-ED82-44BC-9520-E8A7AC416BBEQ36559479-A14D6111-FBA9-4F21-8088-A58E9B2DE65FQ36736410-068302E0-DE26-4278-BE8F-093B05230459Q36812001-AFE58907-A8F1-4EC5-ADA1-6FD670076C44Q37705818-C6488795-450F-4DBF-9A86-91EF8DCC4D4EQ37856451-858B57CC-6AA7-4AA5-B255-7FC35AFC7588Q38943928-3AF9DE34-FB63-4F8C-86D2-4C40E569787AQ39327114-A2C6F4F8-92ED-41C2-A0E1-943BC9157FE5Q39445333-F748180D-3172-4386-8E77-43BB2E8691D3Q39630573-897B1DB8-39BC-42C5-9737-3C68B3150DD3Q39743759-FEA859A4-2647-488D-85BE-255F26F6F917Q39789708-5638BDED-1951-4CEA-BF58-E4CD75308A77Q39852028-15285DA6-79D2-431D-BB2D-B8A974C7629DQ39883935-1FF3F342-86A0-4200-B962-AC50E9D05CFFQ39943472-53A83E54-0C87-4EAF-A8B9-258DCBFD7963Q40101543-3075A2BC-409D-4D0D-91BB-20E203147D4FQ40175806-D31748A7-C0F0-4C40-9D6D-E862CD01C661Q40339509-56307842-2978-4F03-BF29-54EB8ABF4FC3Q40441067-35FDB34D-DF18-4E1A-B622-E61C88158A12Q40446789-C92D0AAB-C2F4-4726-A4B4-36F8EB4456DCQ40515242-542431EE-C5D4-45F8-BBC9-6CD27188EB9FQ41593065-BEAF4AF1-6E12-46A9-AAFD-F0859467B0FCQ41808994-FD660930-C2EA-419B-846E-F18D2A1E619BQ41928227-E9E32EB9-0EFB-4E28-84FE-A22138776B33Q42546463-C224F4CC-7F3C-4641-9649-92A8BDEF16C6Q45328020-52770D35-3D90-430F-9FD6-2EDC2696E408Q45363599-93702011-2513-46F9-A9C1-C30C7993E1FC
P2860
Production of high-titer Epstein-Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Production of high-titer Epste ...... l artificial chromosome system
@en
type
label
Production of high-titer Epste ...... l artificial chromosome system
@en
prefLabel
Production of high-titer Epste ...... l artificial chromosome system
@en
P2093
P2860
P1433
P1476
Production of high-titer Epste ...... l artificial chromosome system
@en
P2093
Kenzo Takada
Mika Tanaka
Misako Yajima
Nazmul Ahsan
Teru Kanda
P2860
P304
P356
10.1128/JVI.78.13.7004-7015.2004
P407
P577
2004-07-01T00:00:00Z